MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Clinical trial NCT02845843 · COMPLETED
Trial details
- NCT number
- NCT02845843
- Sponsor
- King Abdullah International Medical Research Center
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2020-05-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.